NYLI WMC Value Class A MAPAX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 34.36  /  −0.32 %
  • Total Assets 890.9M
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 15,000
  • Status Open
  • TTM Yield 1.26%
  • Turnover 43%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MAPAX

Will MAPAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

NYLI WMC Value Class A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MAPAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alphabet Inc Class C

5.31 49M
Communication Services

JPMorgan Chase & Co

3.44 32M
Financial Services

Merck & Co Inc

2.56 24M
Healthcare

Johnson & Johnson

2.54 23M
Healthcare

Cisco Systems Inc

2.46 23M
Technology

UnitedHealth Group Inc

2.09 19M
Healthcare

Elevance Health Inc

1.80 17M
Healthcare

Pfizer Inc

1.74 16M
Healthcare

Broadcom Inc

1.71 16M
Technology

NetApp Inc

1.69 16M
Technology

Sponsor Center